Archive
View current news AllNewsInnovationInnovationTechnologyTechnologyOtherOther
08 Aug 2024
GrayMatters Health was granted approval for marketing its technology by the Ministry of Health in Israel
28 Dec 2023
Corundum Systems Biology Invests in a Biotech Company Specializing in Improved Reproductive Health for Women
08 Dec 2023
GrayMatters Health was granted approval for marketing its technology by the Ministry of Health in Israel
15 Nov 2023
Joy Ventures Rebrands as Corundum Neuroscience, Launching New Venture Builder and Fund to Spur Neuroscience Technology Innovation
31 May 2023
Corundum Systems Biology Invests in a Biotech Firm Focused on Skin Health
25 Apr 2023
U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD
22 Nov 2022
Corundum Systems Biology Participates in Concerto Biosciences Series A Financing Round raising $23 million
08 Sep 2022
Theranica, a Corundum’s portfolio, raised $45 million in its Series C financing round
19 Jan 2022
Initial Closing of Corundum’s Second Israeli VC Fund, and Start of Consulting Service for New Business Development